ArQule to Release Data at the 2018 American Association for Cancer Research (AACR) Annual Meeting
According to a media release, data will be presented in one oral and nine poster sessions on trials conducted by ArQule and its collaborators for BTK inhibitor, ARQ 531, AKT inhibitors, miransertib and ARQ 751, as well as FGFR inhibitor, derazantinib. The oral presentation will highlight data from a...
Saved in:
Published in | Health & Beauty Close - Up |
---|---|
Format | Newsletter |
Language | English |
Published |
Jacksonville
Close-Up Media, Inc
19.03.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!